A United Kingdom supplier, with 15 awarded contracts, totalling £248.0m, most recently 4 months ago.
This contract involves a framework agreement for the supply of medications aimed at treating obstructive respiratory diseases. The contract is divided into 21 lots, with detailed specifications provided in the tender documents. Suppliers can request clarifications until 20 days before the deadline f
This procurement strategy aims to acquire various medicines and establish a framework agreement/ subsequent contract lasting 36 months to ensure the effective treatment of patients. Suppliers have 20 days to request clarifications before the deadline for submitting offers. The contracting authority
This procurement opportunity involves the supply of essential pharmaceutical products necessary for patient treatment. The absence of these products poses a significant risk to patient health. The contract will cover the purchase of medications as specified in the tender documents, including their p
This is a framework agreement for the supply of pharmaceuticals. Due to space limitations, detailed descriptions and quantities related to the framework agreement and subsequent contracts are specified in the Terms of Reference and the list of lots included in this documentation, excluding VAT. The
This procurement opportunity involves the acquisition of various medicines across 60 different lots. Each lot includes specific medications, such as Olanzapine, Duloxetine, and others, with detailed specifications provided for each item. The contracting authority will respond clearly and completely
This contract involves the supply of a specific medication for the musculoskeletal system, namely Sodium Nusinersenum, in a 12 mg injectable solution, packaged in 5 ml vials. Interested suppliers can request clarifications or additional information regarding the procurement documentation up to 18 da
The upcoming framework agreements involve the supply of medicines, divided into 541 lots, according to the specifications outlined in the terms of reference. The technical specifications for the products involved in this procedure can be found in Annex 1 of the terms of reference. The estimated maxi
This contract involves the supply of pharmaceutical products. The estimated value without VAT ranges from 722,380 lei to 1,667,315 lei. The estimated value for the largest subsequent contract is 198,790 lei. The estimated value for each lot is as follows: Lot 1: 50,000 lei – 110,000 lei, Lot 2: 4,50
This procurement opportunity involves the supply of pharmaceutical products. The estimated value without VAT ranges from 372,230 lei to 830,105 lei. The highest estimated value for a subsequent contract is 115,060 lei. The estimated value for each lot is as follows: Lot 1: 161,700 lei – 369,950 lei,
This contract involves establishing a framework agreement for the supply of essential oncology medicines for hospital medical activities, divided into 59 lots. Each lot includes a detailed list with descriptions, quantities, and estimated values for both minimum and maximum contracts related to subs
